Brain Awareness Week 2022



As part of the Brain Awareness week, Miguel Castanho Lab was at Quinta da Vala primary school Vila Franca de Xira on March 17, 2022 to talk about "Developing smart drugs to treat the brain". Around 64 students from the 3rd-grade learned about the ...
Continue reading 0 Comments

Models of the Blood-Brain Barrier (BBB)



Models of the BBB was an online event with the following theme: "Scientific tools to target the brain", organised by the Faculty of Pharmacy, University of Lisbon (March 18-20, 2022). NOVIRUSES2BRAIN researchers, Miguel Castanho and Vera Neves from faculty of Medicine, University of Lisbon gave two scientific talks about "Drug conjugation as a tool to overcome the BBB" and "Peptides shuttles for receptor-independent ...
Continue reading 0 Comments

Research Exchange between Brazil and Europe



PhD Student, Daniel Gavino, from the Federal University of Rio de Janeiro (Brazil) has visited the Miguel Castanho Lab at Instituto de Medicina Molecular João Lobo Antunes (Lisboa, Portugal) to share his expertise in the animal model of Zika viral infection and to learn more about other biophysical techniques.   
Continue reading 0 Comments

More resistant viruses: Blame the antibiotics



"Did you know that antibiotics are used in cleaning and food? Excessive use makes viruses resistant to treatments", explains Professor Miguel Castanho, principal investigator at Instituto de Medicina Molecular João Lobo Antunes (Lisboa, Portugal), during the E=mc² program on Observador Radio (November 30, 2021). https://observador.pt/programas/e-mc2/virus-mais-resistentes-a-culpa-e-dos-antibioticos/ (in Portuguese)
Continue reading 0 Comments

World Brain Day 2021



Professor Miguel Castanho, principal investigator at Instituto de Medicina Molecular João Lobo Antunes (Lisboa, Portugal), joined the round table to discuss the new Technologies and Innovation Challenges in Neurosciences (July 22, 2021).
Continue reading 0 Comments

XII Biochemistry Day



Professor Miguel Castanho, principal investigator at Instituto de Medicina Molecular João Lobo Antunes (Lisboa, Portugal) spoke about the rationale behind a drug development strategy to inactivate viruses such as Zika and SARS-CoV-2 in the brain, during the XII Biochemistry Day on April 14, 2021 at University of Aveiro.
Continue reading 0 Comments